HiBi proven to be effective AGAINST H1N1 Swine Flu

Recent testing conducted in the USA has shown that 2 products within the HiBi Antiseptics range are effective against H1N1 Swine Flu. HiBiScrub and HiBi Gel Hand Rub+ were tested at different time points and the results showed:

HiBi Gel Hand Rub+ effective in 15 seconds

HiBiScrub effective in 30 seconds

These results are significant as the potential for further more serious outbreaks of the H1N1 virus becomes more likely. The virus, now at pandemic proportions has spread rapidly since an outbreak in Mexico earlier this year. Recommendations from leading healthcare agencies including the CDC (Centre for Disease Control) on good hand hygiene practice suggest one of the best ways to avoid cross contamination and reduce the risk of contracting the virus is to adapt a good hand hygiene routine.

HiBiScrub antimicrobial skin cleanser with added emollients reduced the infectivity of Swine Influenza A H1N1 virus strain 4.25log10(>99.99%)reduction following 30 second, 60 second and 3 minute exposures1. HiBiScrub is aqueous wash containing 4%w/v Chlorhexidine Gluconate and has been proven to remain active against bacteria for up to 6 hours after application.

HiBi Gel Hand Rub+ reduced the infectivity of Swine Influenza A H1N1 virus strain 4.25log10(>99.99%)reduction following 15 second, 30 second and 60 second exposures2. HiBi Gel Hand Rub+ is an alcohol hand rub containing 2%w/v Chlorhexidine Gluconate. The sinkless application of HiBi Gel Hand Rub+ means that not only is the product effective against bacteria for up to 6 hours after application but it means healthcare workers and the general public can use the product without the need for water offering an efficient effective solution in the fight against H1N1.

Products available:

HiBiScrub 500ml / HiBi Gel Hand Rub+ 125ml / HiBi Gel Hand Rub+ 500ml
Fits in HiBi wall brackets* / Pocket size bottle / Fits in HiBi wall brackets*
/ Sales information:
Tel : 0870 116 0999
Email:
Web:

*wall brackets and pumps sold separately.

Mölnlycke Health Care will continuously strive for industry leading reliability and quality in our products and services, in the interest of patient safety, customer satisfaction and business excellence. We will comply with all applicable laws and regulations regarding the safety and efficacy of our products and we will comply with the applicable standards for our processes. As a successful supplier of pharmaceuticals, biocides and medical devices, the quality of our products and services is a critical aspect of our business.

If you have any queries, please don’t hesitate to contact us directly.

*** Please pass this letter to colleagues as appropriate ***

References: 1. Molnlycke Health Care Report REPR0597 2. Molnlycke Health Care Report REPR0597

Mölnlycke Health Care Ltd
Arenson Centre Arenson Way
Dunstable Bedfordshire LU5 5UL UK / / Tel: +44 (0)870 6060766
Fax: +44 (0)870 6081888 / Registered in England
Registration No: 3493645 /